Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CDX-313 for Seasonal Allergic Rhinitis
NCT00940953Phase 2Completed
- Sponsor
- Ligand Pharmaceuticals
- Start
- Feb 2008
- Primary completion
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of CDX-313 in seasonal allergic rhinitis (SAR), sponsored by Ligand Pharmaceuticals. Started Feb 2008; status: completed.
02
Drugs
CDX-313
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT00940953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00940953.